SIRT1 and metabolic dysfunction-associated steatotic liver disease: Here we show that RGZ alters hepatic Sirt1 in a rodent model of NAFLD and improves hepatocyte steatosis accompanied by elevations in adiponectin, Sirt1/6, and their downstream targets as well as AMPK phosphorylation in vitro.